SEC Form 3 · accession 0001209191-17-038273
Senseonics Holdings, Inc. · SENS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 1, 2017
Accepted (ET)
Jun 7, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001616543
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | holding | — | — | — | 28,345,275 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock purchase warrantF1,F2 | $1.79 | holding | — | — | — | — | Jul 15, 2021 | Common stock | 164,284 | — | D |
| Common stock purchase warrantF1,F2 | $1.79 | holding | — | — | — | — | Nov 1, 2020 | Common stock | 809,450 | — | D |
Explanation of responses
- F1Roche Finance Ltd is the direct beneficial owner of these securities of the Issuer. Roche Finance Ltd is a wholly owned subsidiary of Roche Holding Ltd. Roche Holding Ltd is the indirect beneficial owner of these securities of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, if any. Each Reporting Person also disclaims beneficial ownership of any securities of the Issuer that may be or are beneficially owned by any other person or persons other than such Reporting Person. This Form 4 shall not be deemed an admission that any Reporting Person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.
- F2Immediately exercisable.
Remarks
Exhibit 24.1 Power of Attorney